Flputnam Investment Management CO Amgen Inc Transaction History

Flputnam Investment Management CO

$5.29 Billion
Q2 2024

A detailed history of Flputnam Investment Management CO transactions in Amgen Inc stock. As of the latest transaction made, Flputnam Investment Management CO holds 71,062 shares of AMGN stock, worth $22.7 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

71,062

Previous 54,676 29.97%

Holding current value

$22.7 Million

Previous $15.5 Million 42.83%

% of portfolio

0.42%

Previous 0.34%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $4.31 Million - $5.23 Million	16,386 Added 29.97%	71,062 $22.2 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $261,341 - $315,472	972 Added 1.81%	54,676 $15.5 Million
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $101,512 - $114,518	397 Added 0.74%	53,704 $15.5 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $391,602 - $486,184	1,791 Added 3.48%	53,307 $14.3 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $226,054 - $267,305	1,055 Added 2.09%	51,516 $11.4 Million
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $163,020 - $198,694	-722 Reduced 1.41%	50,461 $12.2 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $23,819 - $30,265	-104 Reduced 0.2%	51,183 $13.4 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $45,565 - $51,389	-203 Reduced 0.39%	51,287 $11.6 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $797,795 - $887,806	3,458 Added 7.2%	51,490 $12.5 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $192,519 - $212,976	-878 Reduced 1.8%	48,032 $11.6 Million
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $175,412 - $200,743	-882 Reduced 1.77%	48,910 $11 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $2.32 Million - $2.72 Million	-10,925 Reduced 17.99%	49,792 $10.6 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $178,455 - $197,982	764 Added 1.27%	60,717 $14.8 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $1.15 Million - $1.34 Million	-5,187 Reduced 7.96%	59,953 $14.9 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $3.44 Million - $4.1 Million	-15,904 Reduced 19.62%	65,140 $15 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $491,591 - $546,690	2,095 Added 2.65%	81,044 $20.6 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $3.42 Million - $4.2 Million	17,311 Added 28.08%	78,949 $18.6 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $1.07 Million - $1.42 Million	5,878 Added 10.54%	61,638 $12.5 Million
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $1.59 Million - $2.04 Million	8,401 Added 17.74%	55,760 $13.4 Million
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $366,849 - $439,562	-2,107 Reduced 4.26%	47,359 $9.17 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $651,296 - $763,466	-3,907 Reduced 7.32%	49,466 $9.12 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $508,244 - $572,902	2,810 Added 5.56%	53,373 $10.1 Million
Q4 2018 Feb 22, 2019	BUY	$178.4 - $208.25 $5.31 Million - $6.2 Million	29,779 Added 143.28%	50,563 $9.84 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $3.24 Million - $3.65 Million	17,482 Added 529.44%	20,784 $4.31 Million
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $2.57 Million - $2.89 Million	-15,471 Reduced 82.41%	3,302 $610,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $1.23 Million - $1.44 Million	7,286 Added 63.43%	18,773 $3.2 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $1.53 Million - $1.71 Million	9,090 Added 379.22%	11,487 $2 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $400,994 - $457,827	2,397	2,397 $447,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Account

Flputnam Investment Management CO Amgen Inc Transaction History